The pharmaceutical industry has called for abolishing “off-year” drug price revisions in the run-up to the formulation of the 2024 Basic Policy on Economic and Fiscal Management and Reform (honebuto) later in June. It appears that its lobbying efforts have…
HOME > LATEST
LATEST
-
BUSINESS Astellas Slashes FY2023 Profit Forecasts on Gene Therapy Impairment Loss
April 15, 2024
-
BUSINESS Takeda Files 2-Dose Vial Version of Novavax COVID Vaccine
April 15, 2024
-
BUSINESS MSD Files Keytruda Plus Chemo for Endometrial Cancer in Japan
April 15, 2024
-
REGULATORY Japan to Discuss Orphan Designation for Cannabidiol, 2 More Drugs
April 15, 2024
-
REGULATORY Japan Might Approve 1st Eylea Biosimilar by June, but Not AMD Use
April 15, 2024
-
BUSINESS Wholesaler Purchase Prices of Unprofitable Drugs on Upward Trend after FY2024 Revision
April 12, 2024
-
BUSINESS Japan Autoimmune Drug Market Likely to Top 1 Trillion Yen in 2033: Fuji Keizai
April 12, 2024
-
BUSINESS Smallpox Drug TPOXX Filed in Japan after Govt Request
April 12, 2024
-
REGULATORY Japan Will Persistently Urge China to Release Detained Astellas Employee: Govt
April 12, 2024
-
BUSINESS Moderna, Tohoku Biobank Start Epidemiology Study on Latent Viruses
April 12, 2024
-
BUSINESS ASKA’s Birth Control Pill Makes Mark in Japan PIII Study
April 12, 2024
-
BUSINESS Moderna Plots Successive Launches in Japan, Updated COVID Jab by Fall: Medical Chief
April 11, 2024
-
REGULATORY Alexion’s Voydeya Marks 1st Application of “Early Launch Premium,” but Rate Fully Axed
April 11, 2024
-
REGULATORY Lagevrio to Get 8.2% Price Cut in July, 2.7% for Kerendia: CEA
April 11, 2024
-
REGULATORY Average PMP Rate Hits Record Low at 1.2% in FY2024: MHLW
April 11, 2024
-
BUSINESS GSK, Nagasaki University Begin Large-Scale Epidemiological Study on RSV
April 11, 2024
-
BUSINESS Teijin Out-Licenses Narcolepsy Drug to France’s Bioprojet
April 11, 2024
-
REGULATORY Nobelpharma, Argenx Challenged Initial Pricing for New Meds; Claims Partially Accepted
April 11, 2024
-
REGULATORY Argenx’s gMG Therapy Vyvdura OK’ed for Self-Injection
April 11, 2024
-
BUSINESS AZ/Fujifilm Develop Chemoradiotherapy Database for Lung Cancer
April 10, 2024
ページ
The pharmaceutical industry is ever-changing. Recruiters must evolve accordingly and prepare well in advance for future talent needs.This means predicting the changes and trends that will impact the market, industry, and your organization, and how this will affect talent requirements.…
The Japanese health ministry on December 22 approved a batch of medicines for additional indications, including Otsuka Pharmaceutical’s atypical antipsychotic Rexulti (brexpiprazole) and Zenyaku Kogyo’s anti-CD20 antibody Rituxan (rituximab).Rexulti is now newly indicated for the treatment of depression and depressive…
Authorized generic (AG) strategies taken by innovative drug makers might help soften the impact of generic competition in their businesses but such tactics might also accelerate the application of “G1”/“G2” price cuts for their off-patent brand-name medicines, a Jiho tally…
Japan’s health ministry announced new NHI prices to be applied in April under the FY2022 drug price revision in the official gazette on March 4, with the earlier application of so-called “G1” price cuts to be implemented for the first…